![LESL - Leslies Inc - Stock Price Chart]() |
Market Cap | 74.28M | EPS (ttm) | -0.24 |
P/E | - | EPS this Y | 169.67% |
Forward P/E | 3.98 | EPS next Y | 1343.95% |
PEG | - | EPS past 5Y | - |
P/S | 0.06 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -47.97% |
Dividend | - | Sales Q/Q | -6.11% |
Insider Own | 3.39% | Inst Own | 89.81% |
Insider Trans | 4.27% | Inst Trans | -14.53% |
Short Float | 6.01% | Earnings | May 08/a |
Analyst Recom | 2.92 | Target Price | 1.17 |
Avg Volume | 3.41M | 52W Range | 0.40 - 4.22 |
|
|
Today 04:10PM
|
Leslie's Announces Seasoned Retail Executive Amy College as Chief Merchandising and Supply Chain Officer
(GlobeNewswire) -6.45% |
Jul-11-25 04:00PM
|
Leslie's, SoundHound AI, E.W. Scripps, eHealth, and VF Corp Shares Are Falling, What You Need To Know
(StockStory) -9.20% |
Jul-07-25 07:11AM
|
Why does John Rogers keep buying Leslies Inc.?
(GuruFocus.com) +12.18% |
Jun-19-25 12:06AM
|
3 Reasons to Sell LESL and 1 Stock to Buy Instead
(StockStory) |
Jun-13-25 03:43PM
|
Leslie's, Petco, Bloomin' Brands, ChargePoint, and GEO Group Shares Are Falling, What You Need To Know
(StockStory) -9.64% |
Jun-06-25 12:31AM
|
3 Small-Cap Stocks in the Doghouse
(StockStory) |
May-19-25 04:20PM
|
Level Up Your Pool Game with Leslie's Refreshed Pool Perks Rewards Program
(GlobeNewswire) |
May-10-25 10:56AM
|
Leslies price target lowered to $1.25 from $3 at Telsey Advisory
(TipRanks) |
May-09-25 02:24PM
|
Q2 2025 Leslie's Inc Earnings Call
(Thomson Reuters StreetEvents) |
03:51AM
|
Leslies Inc (LESL) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
(GuruFocus.com) |
|
Leslie's, Inc. engages in the provision of direct-to-consumer pool and spa care services. It offers equipment installation and repair for residential consumers and professional pool operators. The company was founded in 1963 and is headquartered in Phoenix, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lindquist Benjamin | See Remarks | May 23 '25 | Option Exercise | 0.00 | 3,424 | 0 | 8,647 | May 28 04:05 PM | LaBode Moyo | See Remarks | May 18 '25 | Option Exercise | 0.00 | 11,596 | 0 | 91,127 | May 20 04:05 PM | Cramer Naomi | See Remarks | May 18 '25 | Option Exercise | 0.00 | 11,596 | 0 | 39,773 | May 20 04:05 PM | Iskander Anthony A | See Remarks | May 13 '25 | Buy | 0.78 | 63,995 | 49,916 | 65,995 | May 15 04:05 PM | Strain John | Director | May 13 '25 | Buy | 0.79 | 150,000 | 118,500 | 270,000 | May 14 04:05 PM |
|
|
 |
![BBLG - Bone Biologics Corp - Stock Price Chart]() |
Market Cap | 4.65M | EPS (ttm) | -23.25 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 55.67% |
P/S | - | EPS next 5Y | 79.61% |
P/B | 0.54 | EPS Q/Q | 75.61% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.04% | Inst Own | 0.27% |
Insider Trans | 0.00% | Inst Trans | 0.14% |
Short Float | 32.60% | Earnings | May 28 |
Analyst Recom | 1.00 | Target Price | 22.50 |
Avg Volume | 512.93K | 52W Range | 2.87 - 25.50 |
|
|
|
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA. |
|
 |
![IRT - Independence Realty Trust Inc - Stock Price Chart]() |
Market Cap | 4.10B | EPS (ttm) | 0.13 |
P/E | 129.35 | EPS this Y | 24.42% |
Forward P/E | 60.69 | EPS next Y | 33.22% |
PEG | 6.33 | EPS past 5Y | -19.26% |
P/S | 6.40 | EPS next 5Y | 20.43% |
P/B | 1.16 | EPS Q/Q | -53.85% |
Dividend | 3.84% | Sales Q/Q | 0.44% |
Insider Own | 0.87% | Inst Own | 100.85% |
Insider Trans | -0.57% | Inst Trans | 1.17% |
Short Float | 8.23% | Earnings | Apr 30/a |
Analyst Recom | 1.64 | Target Price | 21.68 |
Avg Volume | 2.21M | 52W Range | 17.10 - 22.10 |
|
|
|
Independence Realty Trust, Inc. is a real estate investment trust, which acquires, owns, operates, improves, and manages multifamily apartment communities across non-gateway U.S. markets. It operates through the Same-Store and Non Same-Store segments. The Same-Store segment includes properties that were owned and not a development property at the beginning of the previous year, and that have not been sold or identified as held for sale. The Non Same-Store segment refers to the properties that did not meet the definition of a same-store property as of the beginning of the previous year. The company was founded on March 26, 2009 and is headquartered in Philadelphia, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gebert Richard D | Director | Jul 01 '25 | Sale | 17.58 | 500 | 8,790 | 42,372 | Jul 02 05:30 PM | Gebert Richard D | Director | Jun 02 '25 | Sale | 18.40 | 500 | 9,200 | 42,872 | Jun 02 05:30 PM | Gebert Richard D | Director | May 01 '25 | Sale | 19.01 | 500 | 9,505 | 38,194 | May 02 05:00 PM | SCHAEFFER SCOTT | Chair Board and CEO | Apr 01 '25 | Sale | 21.21 | 10,000 | 212,100 | 873,365 | Apr 02 05:34 PM | Gebert Richard D | Director | Apr 01 '25 | Sale | 21.28 | 500 | 10,640 | 38,694 | Apr 02 05:32 PM |
|
|
|  |
![FG - F&G Annuities & Life Inc - Stock Price Chart]() |
Market Cap | 4.04B | EPS (ttm) | 3.70 |
P/E | 8.12 | EPS this Y | -21.21% |
Forward P/E | 5.46 | EPS next Y | 62.24% |
PEG | 0.57 | EPS past 5Y | - |
P/S | 0.79 | EPS next 5Y | 14.23% |
P/B | 0.93 | EPS Q/Q | -123.24% |
Dividend | 2.90% | Sales Q/Q | -40.73% |
Insider Own | 2.19% | Inst Own | 96.18% |
Insider Trans | 155.56% | Inst Trans | 29.68% |
Short Float | 0.44% | Earnings | May 07/a |
Analyst Recom | 3.00 | Target Price | 34.67 |
Avg Volume | 220.63K | 52W Range | 30.10 - 50.75 |
|
|
|
F&G Annuities & Life, Inc. engages in the provision of fixed annuity and life insurance products. It specializes in life insurance, annuities, retirement planning and wealth transfer. The company was founded in 1959 and is headquartered in Des Moines, IA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blunt Christopher O | Chief Executive Officer | May 19 '25 | Buy | 31.88 | 6,000 | 191,280 | 900,964 | May 19 04:03 PM | Blunt Christopher O | Chief Executive Officer | May 16 '25 | Buy | 32.11 | 5,000 | 160,550 | 894,964 | May 16 05:35 PM | Blunt Christopher O | Chief Executive Officer | May 15 '25 | Buy | 30.78 | 15,000 | 461,700 | 889,964 | May 15 04:27 PM | Blunt Christopher O | Chief Executive Officer | May 12 '25 | Buy | 31.31 | 15,000 | 469,650 | 874,964 | May 12 04:38 PM | Blunt Christopher O | Chief Executive Officer | May 09 '25 | Buy | 30.80 | 10,000 | 307,953 | 859,860 | May 09 07:44 PM |
|
|
 |
![HSON - Hudson Global Inc - Stock Price Chart]() |
Market Cap | 23.30M | EPS (ttm) | -1.22 |
P/E | - | EPS this Y | 125.58% |
Forward P/E | 3.85 | EPS next Y | 900.00% |
PEG | - | EPS past 5Y | -42.68% |
P/S | 0.17 | EPS next 5Y | - |
P/B | 0.59 | EPS Q/Q | 38.27% |
Dividend | - | Sales Q/Q | -5.98% |
Insider Own | 19.01% | Inst Own | 52.36% |
Insider Trans | 0.00% | Inst Trans | -1.88% |
Short Float | 0.09% | Earnings | May 13/b |
Analyst Recom | 1.00 | Target Price | 19.00 |
Avg Volume | 9.41K | 52W Range | 8.28 - 18.99 |
|
|
|
Hudson Global, Inc. is a talent solutions company, which engages in the provision of recruitment outsourcing and total talent solutions to organizations. It operates through the following segments: Americas, Asia Pacific, Europe, Middle East and Africa. The firm's services include complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting. The company was founded in 2003 and is headquartered in Old Greenwich, CT. |
|
|  |
![EXPO - Exponent Inc - Stock Price Chart]() |
Market Cap | 3.67B | EPS (ttm) | 2.04 |
P/E | 35.38 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 6.67% |
P/S | 6.57 | EPS next 5Y | - |
P/B | 8.33 | EPS Q/Q | -11.98% |
Dividend | 1.60% | Sales Q/Q | 0.40% |
Insider Own | 1.07% | Inst Own | 94.36% |
Insider Trans | -1.45% | Inst Trans | 0.62% |
Short Float | 3.90% | Earnings | Jul 31/a |
Analyst Recom | 2.25 | Target Price | 92.00 |
Avg Volume | 318.44K | 52W Range | 72.43 - 115.75 |
|
|
|
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rakow Joseph | Group Vice President | May 27 '25 | Sale | 77.72 | 1,573 | 122,254 | 0 | May 27 08:27 PM | JOSEPH RAKOW | Officer | May 27 '25 | Proposed Sale | 77.72 | 1,573 | 122,254 | | May 27 04:07 PM | JOHN PYE | Officer | May 23 '25 | Proposed Sale | 76.32 | 2,000 | 152,639 | | May 23 06:02 PM | Pye John | Group Vice President | May 23 '25 | Sale | 76.32 | 2,000 | 152,639 | 29,204 | May 23 04:59 PM | James Bradley A | Group Vice President | May 20 '25 | Sale | 79.52 | 2,694 | 214,233 | 0 | May 21 05:04 PM |
|
|
 |
![TNFA - TNF Pharmaceuticals Inc - Stock Price Chart]() |
Market Cap | 1.51M | EPS (ttm) | -6.95 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 50.65% |
P/S | - | EPS next 5Y | - |
P/B | 0.09 | EPS Q/Q | 92.95% |
Dividend | - | Sales Q/Q | - |
Insider Own | 4.98% | Inst Own | 1.44% |
Insider Trans | 0.00% | Inst Trans | -51.69% |
Short Float | 29.03% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 32.00 |
Avg Volume | 5.19M | 52W Range | 0.10 - 2.16 |
|
|
|
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY. |
|
|  |
![CENN - Cenntro Inc - Stock Price Chart]() |
Market Cap | 29.47M | EPS (ttm) | -1.34 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 42.34% |
P/S | 0.98 | EPS next 5Y | - |
P/B | 0.26 | EPS Q/Q | 38.81% |
Dividend | - | Sales Q/Q | -36.82% |
Insider Own | 28.28% | Inst Own | 1.26% |
Insider Trans | 0.00% | Inst Trans | -15.61% |
Short Float | 0.96% | Earnings | Apr 02/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 255.38K | 52W Range | 0.61 - 1.83 |
|
|
|
Cenntro, Inc. is a commercial electric vehicle technology company, which engages in the sale and production of electric vehicles. It provides support to city services, last-mile delivery, and other commercial applications. The company was founded on March 9, 2023 and is headquartered in Freehold, NJ. |
|
|